ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody ...

Manchester City came from behind against Club Brugge to reach the Champions League knockout phase, where they were safely ...

To us, anyway. Over 50 seasons, “Saturday Night Live” has introduced crystal gravy, robot insurance and countless other ...

About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his ...

Not that long ago, I attended a small gathering where a diocesan representative spoke about child protection efforts. “Your child doesn’t have to be looking for porn. Porn is looking for your ...

After what some real estate experts are calling a capital crisis, momentum in Saskatchewan and Canada’s commercial real estate investment market is finally bouncing back. “Interest rates have ...

Bayer expects its pharmaceutical business to return to growth in 2027, unit President Stefan Oelrich said Monday. The German conglomerate is planning to launch new therapies — one that treats a ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Blackstone President Jon Gray said at the time that he believes the extreme distress the commercial real estate market has faced in recent years is beginning to ease up. He now sees opportunity in ...

Highly Pathogenic Avian Influenza has been detected at a commercial turkey facility in Jay County, Indiana. This is the first confirmed positive in Indiana since February 2024 and the first commercial ...

Bayer BAYN-0.85%decrease; red down pointing triangle said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer, a win for ...

In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundup™ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...